Lyra Therapeutics Inc (LYRA): Street Finally Waking Up
Currently, there are 1.32M common shares owned by the public and among those 1.12M shares have been available to trade. The company’s stock has a 5-day price change of 341.18% and 108.33% over the past three months. LYRA shares are trading 96.22% year to date (YTD), with the 12-month market performance up to 22.36% higher. […]
Lyra Therapeutics Inc (NASDAQ: LYRA): Reassessing Prospects
Lyra Therapeutics Inc (LYRA) concluded trading on Wednesday at a closing price of $0.10, with 27.13 million shares of worth about $2.71 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -59.44% during that period and on May 07, 2025 the price saw a […]
Uncovering Institutional Buying In Lyra Therapeutics Inc (NASDAQ: LYRA)
Currently, there are 65.52M common shares owned by the public and among those 54.86M shares have been available to trade. The company’s stock has a 5-day price change of 26.88% and -35.48% over the past three months. LYRA shares are trading -42.83% year to date (YTD), with the 12-month market performance down to -97.72% lower. […]